Hologic plans to acquire Finland-based molecular diagnostic company Mobidiag for $785m to take advantage of the fast-growing acute care market.
Mobidiag develops and markets polymerase chain reaction (PCR) tests for acute conditions, including gastrointestinal and respiratory infections, as well as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?